Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Russian Prospective Multicenter Registry Study of Intravenous Thrombolytic Therapy for Acute Ischemic Stroke.

NCT04674293 is registered in ClinicalTrials.gov with Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health as lead sponsor.

NCT NCT04674293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04674293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Russian Prospective Multicenter Registry Study of Intravenous Thrombolytic Therapy for Acute Ischemic Stroke.
Lead sponsor
Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2020
Completion date
January 1, 2022
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

the aim the study is to collect and analyze data on patients with acute ischemic stroke during intravenous thrombolytic therapy with alteplase